Peramivir is an antiviral drug with activity against the influenza virus. Peramivir is a neuraminidase inhibitor, functioning as a transition-state analog inhibitor of influenza neuraminidase through preventing new viruses from emerging from infected cells. Peramivir injection is used to treat certain types of influenza infection (flu) in adults and children two years of age and older who have had flu symptoms for no longer than two days.
MARKET DYNAMICS
The growing prevalence of viral diseases, rising number of geriatric populations are the major factors propelling the demand for Peramivir. However, the high cost and negative effect of Peramivir is expected to restrain the market's growth during the forecast years. Moreover, the rising healthcare expenditure, market players with advanced products are anticipated to provide an opportunity for market growth.
MARKET SCOPE
The "Peramivir Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Peramivir market with detailed market segmentation by type and application. The Peramivir market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Peramivir market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Peramivir market is segmented on the basis of type and application. Based on type, the market is segmented as solution and solid. Based on application, the market is segmented as influenza A treatment and influenza B treatment.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Peramivir market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Peramivir market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Peramivir market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Peramivir market in these regions.
MARKET PLAYERS
The report covers key developments in the Peramivir market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Peramivir market are anticipated to have lucrative growth opportunities in the future with the rising demand for Peramivir in the global market. Below mentioned is the list of few companies engaged in the Peramivir market.
The report also includes the profiles of key players in Peramivir market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Green Cross Pharma
- Shionogi Co.
- Neopharm
- Moksha8 Pharma
- NT Pharma
- Merck
- Hikma Pharmaceuticals
- Hunan Nucien Pharmaceutical Co., Ltd.
- SCOLR Pharma
- BioCryst Pharmaceuticals, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.